Advances in Aggrephagy: Mechanisms, Disease Implications, and Therapeutic Strategies.
Level 5 - mechanism / opinion, no new human data
Narrative review of cellular mechanisms without original human data
PubMed 39749851 · doi:10.1002/jcp.31512
What was done
This narrative review synthesizes current knowledge on the biological mechanisms of protein aggregate formation, progression, and clearance via the autophagy-lysosomal pathway (aggrephagy), focusing on autophagosome biogenesis, lysosomal digestion, and specific autophagy receptors (P62, NBR1, TAX1BP1, TOLLIP, CCT2).
What was found
The abstract details specific molecular receptors mediating aggregate recognition and degradation in aggrephagy. No quantitative experimental data, effect estimates, or study counts are reported in the abstract.
Why it matters
Clarifying the molecular components of aggrephagy identifies potential biological targets for developing interventions against diseases characterized by toxic protein aggregation, such as neurodegenerative conditions.
Limits
As a narrative review, it presents no original empirical data, quantitative results, or systematic literature search methodology. Clinical efficacy and translational feasibility in humans are not evaluated in the abstract.
Cited by
- supports Most neurodegenerative diseases are caused by the accumulation of toxic protein aggregates resulting from either excessive unfolded protein production or deficiencies in autophagic and lysosomal machineries.